HutchMED (China) LIMITED — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fc13faf4-4636-4ac9-9022-130c9cca25e5/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $456.9M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-023822 |
| FY 2024 | $37.7M | 2024-01-01 – 2024-12-31 | evidence 0001410578-25-000377 |
| FY 2023 | $100.8M | 2023-01-01 – 2023-12-31 | evidence 0001104659-24-028454 |
| FY 2022 | $-360.8M | 2022-01-01 – 2022-12-31 | evidence 0001104659-23-026282 |
| FY 2021 | $-194.6M | 2021-01-01 – 2021-12-31 | evidence 0001104659-22-029752 |
| FY 2020 | $-125.7M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-031897 |
| FY 2019 | $-106.0M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-028220 |
| FY 2018 | $-74.8M | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-001057 |
| FY 2017 | $-26.7M | 2017-01-01 – 2017-12-31 | evidence 0001047469-18-001485 |
| FY 2016 | $11.7M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001647 |
| FY 2015 | $8.0M | 2015-01-01 – 2015-12-31 | evidence 0001558370-17-001647 |
| FY 2014 | $-7.3M | 2014-01-01 – 2014-12-31 | evidence 0001558370-17-001647 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
HutchMED (China) LIMITED — all facts · Revenue · Operating Income